Skip to content

Study Assessing Safety and Performance of OrtoWell Distractor in Patients Undergoing Spinal Surgery

Prospective, Single-Arm, Post-Market Clinical Follow-up (PMCF) Study to Further Assess the Safety and Performance of the OrtoWell® Distractor in Patients Undergoing Spinal Surgery

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03501810
Enrollment
32
Registered
2018-04-18
Start date
2018-04-05
Completion date
2018-09-30
Last updated
2018-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Surgery

Brief summary

Study to Assess the Safety and Performance of the OrtoWell® Distractor in Patients Undergoing Spinal Surgery

Detailed description

This is a Prospective, single-arm, multi-center, observational, post-market clinical follow-up study The OrtoWell® Distractor System (CE marked) is a device intended for separating and holding apart vertebral bodies in the spinal column, to facilitate removal of damaged discs, and implantation of disc prostheses or spinal cage prostheses, as well as for repositioning the vertebral bodies following implantation of disc or cage prostheses The OrtoWell® Distractor System will be used in patients undergoing anterior or lateral spinal surgery, where separation of vertebrae is required, including corpectomy, insertion of disc prosthesis, insertion of an anterior lumbar interbody fusion (ALIF) cage, and tumor surgery The study will enroll up to 32 patients in Germany that require one of the above listed intervention except the patients with a known osteoporosis Study subjects are expected to participate for approximately 30 days following the surgery. Participation will involve a screening period, surgery and scheduled follow-up assessment at 30 days post implant

Interventions

DEVICEDistractor use for vertebrae separation

Distractor use where separation of vertebrae is required, including corpectomy, insertion of disc prosthesis, insertion of an anterior lumbar interbody fusion (ALIF) cage, and tumor surgery

Sponsors

MedPass International
CollaboratorINDUSTRY
OrtoWay AB
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Patients undergoing spinal surgery, where use of the OrtoWell® Distractor System is indicated * Signed written informed consent

Exclusion criteria

* Pregnant patients at the time of spinal surgery * Known osteoporosis * BMI ≥ 30 * Obstacles to performing radioscopy (primarily lateral), such as obesity

Design outcomes

Primary

MeasureTime frameDescription
Device ReliabilityDuring the procedureAssessed by positioning accuracy,holding capability and ease of use

Secondary

MeasureTime frameDescription
Major complicationsIntra and peri operative periodsEvaluation of the major complications (cardiopulmonary, stroke, wound complications)
Hospital stayAssessed at Discharge, approximately 3 daysTotal duration of hospital stay assessed at Discharge
Minor complications1 monthMinor complications at 1 month
All cause mortality1 monthAll cause mortality at 1 month
Length of Procedure (hours)During the procedureLength of Procedure
Re hospitalization1 monthRe hospitalization at 1 month
Device related SAE1 monthDevice related SAE at 1 month
All AEs1 monthAll AEs at 1 month
Re operation1 monthRe operation at 1 month

Countries

Germany

Contacts

Primary ContactStan Mikulowski
stan.mikulowski@ortoway.com46 8 558 093 69

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026